Summary
Specialty EHR platforms are increasingly evolving beyond basic systems of record into broader clinical and financial operating platforms built around the workflows of individual specialties. Horizontal EHRs can struggle with requirements such as oncology treatment pathways, ophthalmic imaging, specialty billing and behavioral-health documentation, creating room for vertical platforms that can embed more deeply into day-to-day clinical operations.
The economic opportunity increasingly extends beyond the core EHR subscription. Once embedded in provider workflows, vendors can expand into practice management, RCM, payments, premium modules, AI-enabled automation and clinical-data products, increasing revenue per customer while reinforcing switching costs. AI is becoming particularly important across documentation, coding, clinical decision support and administrative workflows, while data-rich specialties such as oncology are creating additional opportunities through RWD/RWE and life-sciences partnerships.
The broader EHR and PACS market was estimated at $56.25 billion in 2025 and is projected to reach $113.64 billion by 2030, while individual verticals such as OB/GYN already represent meaningful standalone markets. Continued consolidation and recent M&A activity also point toward growing strategic interest in specialty workflows, AI capabilities and integrated clinical infrastructure.
Key Takeaways
Verticalization is gaining momentum: Specialty-specific clinical, imaging, regulatory and reimbursement requirements are supporting demand for purpose-built EHR platforms rather than heavily customized horizontal systems.
The EHR is increasingly the land product: Vendors are expanding into practice management, RCM, payments, AI and other adjacent solutions to increase wallet share and platform stickiness.
AI is becoming embedded in the workflow: Documentation, coding, decision support and administrative automation are creating new monetization opportunities while reducing provider burden.
Specialty economics vary materially: Oncology, cardiology, behavioral health, ophthalmology, women’s health and other verticals each create distinct workflow requirements and monetization opportunities.
Clinical data can become a strategic asset: In data-rich specialties, longitudinal records can support RWD/RWE, clinical research and life-sciences partnerships, adding a secondary monetization layer beyond provider software budgets.
Investor interest extends beyond pure SaaS: Recurring EHR subscriptions remain the foundation, but premium modules, AI, RCM, payments and data licensing can improve ARPU, revenue visibility and strategic differentiation.